MDAI

ADVERTISEMENT

Identification

Molecular formula
C12H17NO2
CAS Number
82801-81-8
IUPAC Name
1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine
Molecular Weight
191.25g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1450g/cm3
Synonyms
3754-26-5
Interesting facts

Exploring 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine

This intriguing compound, known as 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine, is noteworthy for several reasons, particularly in medicinal chemistry and drug discovery.

Key Characteristics

  • Structural Complexity: The compound features a unique structural configuration that includes a benzodioxin moiety, which contributes to its bioactive properties.
  • Potential Applications: Compounds with similar structures have been explored for their neuroprotective and antidepressant effects, making them candidates for therapeutic research.
  • Research Significance: The presence of the ethanamine segment suggests potential interactions with neurotransmitter systems, which is a critical aspect for developing psychoactive medications.

Research & Implications

The exploration of such compounds is crucial in the quest for new drugs that could revolutionize the treatment of mood disorders. According to scientists, "Understanding the underlying mechanisms of these compounds may lead to innovative therapies." The benzodioxin component is particularly interesting due to its ability to modulate various biological pathways.

Future Directions

Ongoing research aims to elucidate the pharmacological properties and mechanisms of action of 1-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-ethyl-ethanamine. With advancements in synthetic methodologies and biological screening, there is great excitement about the potential to develop new medications from such compounds.

Overall, this compound stands at the crossroads of chemistry and medicine, making it a compelling subject for further study and exploration.

ADVERTISEMENT